Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus

被引:15
|
作者
Katz, Patricia [1 ,6 ]
Wan, George J. [2 ]
Daly, Paola [3 ]
Topf, Lauren [3 ]
Connolly-Strong, Erin [2 ,5 ]
Bostic, Ryan [4 ]
Reed, Michael L. [4 ]
机构
[1] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA
[2] Mallinckrodt Pharmaceut, Global Head Hlth Econ & Outcomes Res, Bedminster, NJ USA
[3] Lupus Fdn Amer, Washington, DC USA
[4] Vedanta Res, Chapel Hill, NC USA
[5] Mallinckrodt Pharmaceut, Field Med Affairs, Bedminster, NJ USA
[6] Univ Calif San Francisco, Arthrit Res Grp, 3333 Calif St, San Francisco, CA 94143 USA
关键词
Systemic lupus erythematosus; Flare; Disease activity; Quality of life; Role functioning; DISEASE-ACTIVITY; IMPACT; BURDEN; DAMAGE; PRODUCTIVITY; DISCORDANCE; PREVALENCE; VALIDATION; PREDICTORS; PHYSICIANS;
D O I
10.1007/s11136-020-02572-9
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose To understand the influence of the systemic lupus erythematosus (SLE)-related flares on patient's health-related quality of life (HRQoL). Methods An online survey included individuals with self-reported physician's diagnosis of SLE or lupus nephritis (LN). Lupus impact tracker (LIT) assessed lupus symptoms and HRQoL, SLE-Family questionnaire measured family role functioning, and Healthy Days Core Module (HDCM) measured overall mental and physical health. Chi-square and analysis of variance evaluated differences by flare frequency. Multivariable linear regression and generalized linear models evaluated the independent relationships of flare frequency to HRQoL. Results 1066 respondents with SLE or LN completed the survey. Mean (SD) duration of illness was 12.4 (10.1) years. 93.4% (n = 996) were women, 82.3% (n = 830) were White, and 49.7% (n = 530) were employed or students. More frequent flares were associated with significantly worse scores on all HRQoL measures: LIT (adjusted means: 0 flares, 31.8; 1-3 flares, 47.0; 4-6 flares, 56.1; >= 7 flares, 63.6;P < 0.001); SLE-Family (adjusted means: 0 flares, 3.1; 1-3 flares 3.8; 4-6 flares, 4.3; >= 7 flares, 4.6,P < 0.001); HDCM unhealthy days (0 flares, 8.7; 1-3 flares, 17.4; 4-6 flares, 21.5; >= 7 flares, 26.2 days,P < 0.001). Conclusion Lupus flares contributed to impaired functional and psychological well-being, family functioning, and number of monthly healthy days. Better understanding of the burden of flare activity from the patient's perspective will support a holistic approach to lupus management.
引用
收藏
页码:3251 / 3261
页数:11
相关论文
共 50 条
  • [41] Association of Limited Health Literacy With Clinical and Patient-Reported Outcomes in Individuals With Systemic Lupus Erythematosus
    Maheswaranathan, Mithu
    Boan, Andrea D.
    Ramakrishnan, Viswanathan
    Johnson, Hetlena
    Rose, Jillian
    Dismuke-Greer, Clara L.
    Oates, Jim C.
    Egede, Leonard E.
    Williams, Edith
    ACR OPEN RHEUMATOLOGY, 2024, 6 (11) : 780 - 789
  • [42] Patient-reported outcomes and healthcare resource utilization in systemic lupus erythematosus: impact of disease activity
    Touma, Zahi
    Costenbader, Karen H.
    Hoskin, Ben
    Atkinson, Christian
    Bell, David
    Pike, James
    Berry, Pamela
    Karyekar, Chetan S.
    BMC RHEUMATOLOGY, 2024, 8 (01)
  • [43] Explaining the Discrepancy between Physician and Patient-Reported Measures of Disease Activity in Systemic Lupus Erythematosus
    Harris, Nathaniel J.
    Eudy, Amanda M.
    Clowse, Megan E. B.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [44] Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark
    Troldborg, Anne
    Remkus, Lauren
    Eek, Daniel
    Deleuran, Bent
    LUPUS, 2024, 33 (09) : 962 - 973
  • [45] Patient-Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis
    Harris, Nathaniel
    Eudy, Amanda M.
    Clowse, Megan E. B.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [46] Fighting Fatigue in Systemic Lupus Erythematosus: Experience of Dehydroepiandrosterone on Clinical Parameters and Patient-Reported Outcomes
    Skoglund, Oliver
    Walhelm, Tomas
    Thyberg, Ingrid
    Eriksson, Per
    Sjowall, Christopher
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (18)
  • [47] PSYCHOMETRIC VALIDATION OF PATIENT-REPORTED OUTCOME MEASURES OF PAIN IN US PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Naegeli, A. N.
    Al Sawah, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1166 - 1166
  • [48] Patient-Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis
    Harris, Nathaniel
    Eudy, Amanda
    Clowse, Megan
    ARTHRITIS CARE & RESEARCH, 2019, 71 (03) : 390 - 397
  • [49] The Impact of Limited Health Literacy on Patient-Reported Outcomes (PROs) in Systemic Lupus Erythematosus (SLE)
    Katz, Patricia P.
    Dall'Era, Maria
    Trupin, Laura
    Lanata, Cristina
    Rush, Stephanie
    Helmick, Charles G.
    Criswell, Lindsey A.
    Yazdany, Jinoos
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [50] Relationship Between Flare and Health-related Quality of Life in Patients with Systemic Lupus Erythematosus
    Zhu, Tracy Y.
    Tam, Lai-Shan
    Lee, Vivian W. Y.
    Lee, Kenneth K.
    Li, Edmund K.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (03) : 568 - 573